ArticleJournal of imaging informatics in medicine2026
BreasTransNeXt: An Enhanced Multi-Module Vision Transformer For Early Breast Cancer Diagnosis.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ViT-FuseNet: Same-Patient MRI-Pathology Feature Fusion for Multimodal Breast Cancer Diagnosis.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) represents the most common and one of the most lethal malignancies among women globally, ranking second only to lung cancer in terms of mortality. Early diagnosis is critically important, as treatment outcomes are significantly improved when BC is identified at an initial stage. Although considerable research has been conducted on BC classification utilizing deep learning techniques, there remains a deficiency of comprehensive models that effectively integrate robust feature extraction with balanced learning methodologies. To address this limitation, we introduce BreasTransNeXt, a new hybrid deep learning framework that synergizes the convolutional inductive bias inherent in ConvFormer with the efficient global attention mechanisms of a hybrid transformer architecture, thereby facilitating robust multi-scale feature representation. Furthermore, to mitigate class imbalance and enhance model generalization, the BC dataset is augmented through the application of a Wasserstein Generative Adversarial Network with gradient penalty, which generates high-fidelity synthetic images for both malignant and healthy classes. Additionally, BreasTransNeXt incorporates a hybrid attention mechanism comprising of local, channel, and global branches, which are integrated via adaptive gating; this design enhances feature representation by capturing fine-grained lesion characteristics, inter-feature correlations, and long-range contextual dependencies. The proposed model is rigorously evaluated against traditional convolutional neural network approaches and state-of-the-art vision transformer architectures. Experimental findings demonstrate that BreasTransNeXt consistently outperforms these methods, achieving an accuracy of 0.9710, recall of 0.9808, precision of 0.9808, and F1-score of 0.9808, thereby underscoring its potential as a reliable tool for early BC detection.
Indexed as
Identifiers
41714572What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.